Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith D Lindor

Showing results (71-80 of 261) with videos related to

Pageof 27
Sort By:
Minerva Gastroenterologica E Dietologica|June 22, 2019
Cancer risk, screening and surveillance in primary sclerosing cholangitisDavid M Chascsa, Keith D Lindor
Expert Opinion on Pharmacotherapy|October 26, 2012
Current pharmacotherapy for cholestatic liver diseaseElizabeth J Carey, Keith D Lindor
American Journal of Therapeutics|September 23, 2009
Antibiotics for the treatment of primary sclerosing cholangitisDiaa Aldin H Elfaki, Keith D Lindor
Digestive Diseases and Sciences|March 1, 2012
The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver diseasePhunchai Charatcharoenwitthaya, Keith D Lindor, Paul Angulo
Pediatric Gastroenterology, Hepatology & Nutrition|October 15, 2016
Oral Vancomycin Therapy in a Child with Primary Sclerosing Cholangitis and Severe Ulcerative ColitisCynthia Buness, Keith D Lindor, Tamir Miloh
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2007
Risk of lymphoma in primary biliary cirrhosisChakri Panjala, Jayant A Talwalkar, Keith D Lindor
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 20, 2004
Use of herbal supplements for chronic liver diseaseCynthia Levy, Leonard D Seeff, Keith D Lindor
The American Journal of Gastroenterology|July 6, 2004
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver diseaseLeon A Adams, Keith D Lindor, Paul Angulo
Hepatology (Baltimore, Md.)|July 28, 2011
Cancer surveillance in patients with primary sclerosing cholangitisNataliya Razumilava, Gregory J Gores, Keith D Lindor
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2017
Old and new treatments for primary biliary cholangitisDavid Chascsa, Elizabeth J Carey, Keith D Lindor
Pageof 27

Showing results (71-80 of 261) with videos related to

Sort By:
Pageof 27
Minerva Gastroenterologica E Dietologica|June 22, 2019
Cancer risk, screening and surveillance in primary sclerosing cholangitisDavid M Chascsa, Keith D Lindor
Expert Opinion on Pharmacotherapy|October 26, 2012
Current pharmacotherapy for cholestatic liver diseaseElizabeth J Carey, Keith D Lindor
American Journal of Therapeutics|September 23, 2009
Antibiotics for the treatment of primary sclerosing cholangitisDiaa Aldin H Elfaki, Keith D Lindor
Digestive Diseases and Sciences|March 1, 2012
The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver diseasePhunchai Charatcharoenwitthaya, Keith D Lindor, Paul Angulo
Pediatric Gastroenterology, Hepatology & Nutrition|October 15, 2016
Oral Vancomycin Therapy in a Child with Primary Sclerosing Cholangitis and Severe Ulcerative ColitisCynthia Buness, Keith D Lindor, Tamir Miloh
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2007
Risk of lymphoma in primary biliary cirrhosisChakri Panjala, Jayant A Talwalkar, Keith D Lindor
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 20, 2004
Use of herbal supplements for chronic liver diseaseCynthia Levy, Leonard D Seeff, Keith D Lindor
The American Journal of Gastroenterology|July 6, 2004
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver diseaseLeon A Adams, Keith D Lindor, Paul Angulo
Hepatology (Baltimore, Md.)|July 28, 2011
Cancer surveillance in patients with primary sclerosing cholangitisNataliya Razumilava, Gregory J Gores, Keith D Lindor
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2017
Old and new treatments for primary biliary cholangitisDavid Chascsa, Elizabeth J Carey, Keith D Lindor
Pageof 27